Non-cardiac Chest Pain: Effect of Cognitive Therapy Administered as Guided Self-help
2 other identifiers
interventional
160
1 country
1
Brief Summary
This study aims to test an easily implementable web-based cognitive behaviour therapy (CBT) self-help intervention designed for non-cardiac chest pain patients, and compare effectiveness and cost-effectiveness to treatment as usual in an randomized controlled trial (RCT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2017
CompletedFirst Posted
Study publicly available on registry
March 30, 2017
CompletedStudy Start
First participant enrolled
April 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFebruary 1, 2023
January 1, 2023
2.7 years
February 16, 2017
January 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Cardiac Anxiety Questionnaire (CAQ)
CAQ is an 18-item self-report-questionnaire which measures hearth related anxiety/fear, attention, avoidance and safety seeking behavior. Each item is rated on a five-point Likert scale ranging from 0 to 4. Total range 0-72 where higher score represents more symptoms. Primary outcome is difference in mean score between intervention arm and control arm for CAQ at end of treatment (6 weeks after randomization for both arms). Difference in mean scores between arms will also be assessed at pretreatment/baseline, and at 3 months and 12 months after end of treatment (18 weeks and 58 weeks after randomization). There is no predefined clinical relevant effect for this measure, we use a distribution based method and define clinical relevant effect as improvement of more than 0.5 standard deviation compared to baseline.
58 weeks
Change in Body Sensations Questionnaire (BSQ)
BSQ is an 17-item self-report-questionnaire which measures fear of different bodily sensations. Each item is rated on a five-point Likert scale ranging from 1 to 5. Total range 17-85 where higher score represents more symptoms. Primary outcome is difference in mean score between intervention arm and control arm for BSQ at end of treatment (6 weeks after randomization for both arms). Difference in mean scores between arms will also be assessed at pretreatment/baseline, and at 3 months and 12 months after end of treatment (18 weeks and 58 weeks after randomization). There is no predefined clinical relevant effect for this measure, we use a distribution based method and define clinical relevant effect as improvement of more than 0.5 standard deviation compared to baseline.
58 weeks
Secondary Outcomes (5)
Change in Brief Illness Perception Questionnaire (BIPQ)
58 weeks
Change in Patient Health Questionnaire (PHQ-9)
58 weeks
Change in General perceived Self-Efficacy Scale
58 weeks
Change in EQ-5D-5L
58 weeks
Health care costs
58 weeks
Other Outcomes (1)
Composite measures
58 weeks
Study Arms (2)
Intervention group
EXPERIMENTALThe intervention group will receive guided self-help comprising six web-based sessions, comprising information, exposure to physical activity, how worry can excess pain, physical reactions to pain and worry, consequences of avoidance, and specific panic treatment. The first session will be done at the hospital before discharge, the others at home. Between sessions there will be a brief telephone contact with a project worker.
Control group
NO INTERVENTIONThis group will receive treatment as usual, which is no specific treatment. They can however use the general health system as they like.
Interventions
Eligibility Criteria
You may qualify if:
- Non-Cardiac Chest Pain
You may not qualify if:
- Language difficulties
- Unable to perform at least moderate physical activity due to physical constraints
- Obvious cognitive impairment (e.g mentally retarded, psychotic, dementia or intoxicated)
- no regular access to a computer/tablet computer with internet connection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sorlandet Sykehus HF
Kristiansand, Vest Agder, 4604, Norway
Related Publications (2)
Thesen T, Himle JA, Pripp AH, Sunde T, Walseth LT, Thorup F, Gallefoss F, Jonsbu E. Patients with depression symptoms are more likely to experience improvements of internet-based cognitive behavioral therapy: a secondary analysis of effect modifiers in patients with non-cardiac chest pain in a randomized controlled trial. BMC Psychiatry. 2023 Oct 14;23(1):751. doi: 10.1186/s12888-023-05238-1.
PMID: 37838653DERIVEDThesen T, Himle JA, Martinsen EW, Walseth LT, Thorup F, Gallefoss F, Jonsbu E. Effectiveness of Internet-Based Cognitive Behavioral Therapy With Telephone Support for Noncardiac Chest Pain: Randomized Controlled Trial. J Med Internet Res. 2022 Jan 24;24(1):e33631. doi: 10.2196/33631.
PMID: 35072641DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Frode Gallefoss, MD, PhD
Head of Clinical Research, Sørlandet HF.
- PRINCIPAL INVESTIGATOR
Liv T Walseth, MD, PhD
Researcher, Sørlandet HF
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2017
First Posted
March 30, 2017
Study Start
April 3, 2017
Primary Completion
December 19, 2019
Study Completion
January 1, 2024
Last Updated
February 1, 2023
Record last verified: 2023-01